DrugPatentWatch Database Preview
TRIZIVIR Drug Profile
Which patents cover Trizivir, and when can generic versions of Trizivir launch?
Trizivir is a drug marketed by Viiv Hlthcare and is included in one NDA.
The generic ingredient in TRIZIVIR is abacavir sulfate; lamivudine; zidovudine. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the abacavir sulfate; lamivudine; zidovudine profile page.
Summary for TRIZIVIR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Clinical Trials: | 20 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TRIZIVIR |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TRIZIVIR |
| DailyMed Link: | TRIZIVIR at DailyMed |
Recent Clinical Trials for TRIZIVIR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| AIDS Clinical Trials Group | Phase 3 |
| Ines Perez | Phase 4 |
Recent Litigation for TRIZIVIR
Identify potential future generic entrants
District Court Litigation
| Case Name | Date |
|---|---|
| ViiV Healthcare UK Ltd. v. Lupin Ltd. | 2011-06-29 |
| Glaxo Group Ltd. v. Lupin Ltd. | 2008-08-29 |
PTAB Litigation
| Petitioner | Date |
|---|---|
| Teva Pharmaceuticals USA, Inc. | 2015-01-08 |
| Apotex Corp. | 2014-06-02 |
Pharmacology for TRIZIVIR
Paragraph IV (Patent) Challenges for TRIZIVIR
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| TRIZIVIR | TABLET;ORAL | abacavir sulfate; lamivudine; zidovudine | 021205 | 2011-03-22 |
US Patents and Regulatory Information for TRIZIVIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | TRIZIVIR | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 021205-001 | Nov 14, 2000 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRIZIVIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | TRIZIVIR | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 021205-001 | Nov 14, 2000 | Start Trial | Start Trial |
| Viiv Hlthcare | TRIZIVIR | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 021205-001 | Nov 14, 2000 | Start Trial | Start Trial |
| Viiv Hlthcare | TRIZIVIR | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 021205-001 | Nov 14, 2000 | Start Trial | Start Trial |
| Viiv Hlthcare | TRIZIVIR | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 021205-001 | Nov 14, 2000 | Start Trial | Start Trial |
| Viiv Hlthcare | TRIZIVIR | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 021205-001 | Nov 14, 2000 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
